Related Experiment Video
Updated: Jul 18, 2026

Phospholipid Mediator Induced Transformation in Three-Dimensional Cultures
Published on: July 27, 2022
Critical role for matrix metalloproteinase-9 in platelet-activating factor-induced experimental tumor metastasis
Hyun-Mi Ko1, Jee-Hae Kang, Bongnam Jung
1Department of Biological Sciences, College of Natural Sciences, Chonnam National University, Kwangju 500-757, Republic of Korea.
Abstract:
In this study, the roles of matrix metalloproteinase (MMP)-2 and MMP-9 in platelet-activating factor (PAF)-induced experimental pulmonary metastasis of the murine melanoma cell, B16F10, were investigated. An injection of PAF resulted in increases in mRNA expression, protein levels and the activities of both MMP-2 and MMP-9 in the lungs. The overall expression of MMP-9 was stronger than that of MMP-2. The increased MMP-9 expression was inhibited by both NF-kappaB and AP-1 inhibitors, whereas the increased MMP-2 expression was inhibited by only AP-1 inhibitors. Immunohistochemical analysis revealed that MMP-9 was expressed in bronchial epithelial cells as well as in the walls of blood vessels, whereas MMP-2 expression was observed only in bronchial epithelial cells. PAF significantly enhanced the pulmonary metastasis of B16F10, which was inhibited by both NF-kappaB and c-jun inhibitors. MMP-9 inhibitor, but not that of MMP-2, completely inhibited PAF-induced B16F10 metastasis. These data indicate that MMP-9, the expression of which was regulated by NF-kappaB and AP-1, plays a critical role in PAF-induced enhancement of pulmonary melanoma metastasis.
Insights
Platelet-activating factor (PAF) promotes melanoma lung metastasis by increasing matrix metalloproteinase-9 (MMP-9) expression. Inhibiting MMP-9 effectively blocks this PAF-induced metastasis, highlighting MMP-9
Area of Science:
- Biochemistry
- Oncology
- Cell Biology
Background:
- Platelet-activating factor (PAF) is implicated in inflammatory and metastatic processes.
- Matrix metalloproteinases (MMPs), particularly MMP-2 and MMP-9, are crucial in extracellular matrix remodeling and cancer metastasis.
- The specific roles of MMP-2 and MMP-9 in PAF-induced pulmonary metastasis require elucidation.
Purpose of the Study:
- To investigate the involvement of matrix metalloproteinase (MMP)-2 and MMP-9 in platelet-activating factor (PAF)-induced experimental pulmonary metastasis of B16F10 melanoma cells.
- To determine the regulatory pathways (NF-kappaB, AP-1) controlling MMP expression in this model.
- To assess the therapeutic potential of MMP inhibitors in preventing PAF-mediated lung metastasis.
Main Methods:
- Murine melanoma cells (B16F10) were used in an experimental pulmonary metastasis model.
- Platelet-activating factor (PAF) was administered to induce metastasis.
- mRNA expression, protein levels, and enzymatic activities of MMP-2 and MMP-9 were quantified.
- Inhibitors of NF-kappaB and AP-1 signaling pathways were employed.
- Immunohistochemistry was used to localize MMP-9 and MMP-2 expression.
- The effect of specific MMP-2 and MMP-9 inhibitors on B16F10 metastasis was evaluated.
Main Results:
- PAF administration significantly increased lung mRNA, protein levels, and activity of both MMP-2 and MMP-9.
- MMP-9 expression was notably stronger than MMP-2 and was regulated by both NF-kappaB and AP-1.
- MMP-2 expression was regulated solely by AP-1.
- Immunohistochemistry showed MMP-9 in bronchial epithelial cells and blood vessel walls, while MMP-2 was confined to bronchial epithelial cells.
- PAF-induced B16F10 pulmonary metastasis was significantly inhibited by NF-kappaB and c-jun (AP-1) inhibitors.
- A specific MMP-9 inhibitor completely abolished PAF-induced B16F10 metastasis, whereas an MMP-2 inhibitor had no effect.
Conclusions:
- Matrix metalloproteinase-9 (MMP-9), regulated by NF-kappaB and AP-1 signaling, plays a critical role in PAF-induced enhancement of pulmonary melanoma metastasis.
- MMP-9 is a key mediator in the process of PAF-driven melanoma cell dissemination to the lungs.
- Targeting MMP-9 presents a potential therapeutic strategy for inhibiting PAF-mediated melanoma lung metastasis.
More Related Videos
Related Concept Videos
Role of Matrix Metalloproteases in Degradation of ECM
A...
Metastasis
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
The Tumor Microenvironment
Intracellular Signaling Affects Focal Adhesions
Some...
Cancer Cell Migration through Invadopodia
Mitogens and the Cell Cycle
